Prostate cancer-specific mortality after prostatectomy or radiation therapy: Influence of PSA-DT

	Prostate cancer-specific survival
	PSA-DT <3 months	PSA-DT ≥3 months
3 years
Surgery	84.1	99.8
Radiation	79.1	99.6
5 years
Surgery	68.8	99.4
Radiation	61.6	96.1
8 years
Surgery	51.5	98.9
Radiation	41.6	87.6

PSA-DT: prostate-specific antigen doubling time.

Data from: D'Amico, AV, Moul, JW, Carroll, PR, et al. Surrogate end point for prostate cancer-specific mortality after radical prostatectomy or radiation therapy. J Natl Cancer Inst 2003; 95:1376.

Graphic 55120 Version 2.0

خرید پکیج

Prostate cancer-specific mortality after prostatectomy or radiation therapy: Influence of PSA-DT